Search

Search results

87 results found

Kia Byrd - Vice President

Kia Byrd is a current MS1 in the New Pathway program and native of Jackson, Mississippi. In May 2014, she received a BS degree in biology from the illustrious Howard University. A proud Bison, Kia was active in a number of organizations on Howard’s campus, including America’s Promise—a mentoring...

David Osayande - Pipeline Coordinator

David Osayande is a current first year medical student in the New Pathway Program. His family is Nigerian, but he was born in Germany and raised in Brooklyn, New York. He attended New York University as a HEOP Scholar and graduated with a B.S. in Chemistry in 2013. During his time at NYU, he taught...

Abnormal white matter tractography of visual pathways detected by high-angular-resolution diffusion imaging (HARDI) corresponds to visual dysfunction in cortical/cerebral visual impairment

Bauer, Corinna, Gena Heidary, Bang-Bon Koo, Ronald Killiany, Peter Bex, and Lotfi Merabet. 2014. “Abnormal White Matter Tractography of Visual Pathways Detected by High-Angular-Resolution Diffusion Imaging (HARDI) Corresponds to Visual Dysfunction in Cortical/Cerebral Visual Impairment”. J AAPOS 18 (4): 398-401.

The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation

Brodowska, Katarzyna, Ahmad Al-Moujahed, Anna Marmalidou, Melissa Meyer Zu Hörste, Joanna Cichy, Joan Miller, Evangelos Gragoudas, and Demetrios Vavvas. 2014. “The Clinically Used Photosensitizer Verteporfin (VP) Inhibits YAP-TEAD and Human Retinoblastoma Cell Growth in Vitro Without Light Activation”. Exp Eye Res 124: 67-73.